Literature DB >> 19094885

[Spanish version of the Severity of Dependence Scale (SDS)].

Francisco González-Saiz, Carlos de Las Cuevas, Gregorio Barrio, Antonia Domingo-Salvany.   

Abstract

Mesh：

Year:  2008        PMID： 19094885     DOI： 10.1016/s0025-7753(08)75509-x

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  5 in total

1.  Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders.

Authors:  M Chahua; A Sánchez-Niubò; M Torrens; L Sordo; M J Bravo; M T Brugal; A Domingo-Salvany
Journal:  Qual Life Res       Date:  2015-02-15       Impact factor: 4.147

2.  CANreduce-SP-adding psychological support to web-based adherence-focused guided self-help for cannabis users: study protocol for a three-arm randomized control trial.

Authors:  F Fonseca; J I Mestre-Pintó; M P Schaub; C Baumgartner; M Alias-Ferri; M Torrens
Journal:  Trials       Date:  2022-06-22       Impact factor: 2.728

3.  A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment.

Authors:  Ignacio Basurte-Villamor; Pablo Vega; Carlos Roncero; José Martínez-Raga; Lara Grau-López; Lourdes Aguilar; Marta Torrens; Nestor Szerman
Journal:  Neuropsychiatr Dis Treat       Date:  2022-05-04       Impact factor: 2.989

4.  Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study.

Authors:  Nestor Szerman; Ignacio Basurte-Villamor; Pablo Vega; Jose Martinez-Raga; Carlos Parro-Torres; Julia Cambra Almerge; Lara Grau-López; Mario De Matteis; Francisco Arias
Journal:  Drugs Real World Outcomes       Date:  2020-03

5.  Dual Disorders in the Consultation Liaison Addiction Service: Gender Perspective and Quality of Life.

Authors:  Teresa Ferrer-Farré; Fernando Dinamarca; Joan Ignasi Mestre-Pintó; Francina Fonseca; Marta Torrens
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.